Looking for more information about our CellRaft AIR® System or CytoSort® Arrays?
Download the following brochures.
CytoSort ® Arrays
Companion to the CellRaft AIR, CytoSort Arrays allow gentle sorting of cells, resulting in cells that are more viable and have less perturbed phenotypes compared to traditional methods.
Download the CytoSort Array brochure to get more information.
CRISPR & Cell Line Development
The CellRaft AIR System is a fully automated and hands-free imaging and isolation solution for limiting manual screening and cell manipulation efforts.
Eliminate doublets and debris by automated selection of the best single cells that maintain their native phenotype for downstream genomic analysis.
Download the Genomics application brochure to get more information.
The CellRaft AIR System’s Stem Cell Workflow can eliminate expensive additives and provide greater yields to accelerate the path to drug discovery and new therapies.
Download our Stem Cell application brochure to learn more.
Tracking and traceability is critical for CROs. Using brightfield microscopy, the CellRaft AIR System identifies single cells and serially images over time to capture complete growth records of clonal development.
Download our CellRaft AIR System brochure to learn more.
Interested in reading about our recent updates? RaftNotes are publications specifically for AIR System users that features application updates and product notes.
The advancement of 3D culture systems has transformed cell-based assays for biological research and drug discovery due to their ability to re-capitulate the structure and cellular complexity of in vivo tissues. Organoids are unique due in their ability to self-organize and closely replicate in vivo pathophysiology. Most laboratory instruments employed to assess endpoints using traditional organoid cultures have limitations that preclude assessment of the heterogeneity within the population or retrieval of single, intact 3D structures for downstream applications.
The AIR System offers unique advantages over technologies, such as flow cytometry and droplet dispensers, designed to assess cells in suspension. The limitations to other technologies include impacts on cell viability, inability to interrogate small numbers of cells, and reliance on fluorescent markers or staining for cell characterization. To demonstrate the value of the CellRaft technology for use in suspension cell line development, we have established methodologies for attaching suspension cells to the CytoSort Arrays during single cell expansion while still allowing the cells to expand in suspension after the clone of interest has been isolated.
Therapeutic proteins play an essential role in the biological pharmaceutical market and are used in the treatment of many diseases, such as diabetes, cancer, and anemia. One of the main goals in recombinant protein development is the establishment of high-quality monoclonal cell lines that consistently express large amounts of the given protein. Chinese hamster ovary (CHO) cell lines have dominated the industry as commercial hosts for recombinant protein production; however, the process of generating a homogenous CHO cell line is not trivial.